KOPRAN
|
KOPRAN Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹68 Cr | ₹36 Cr | ₹82 Cr | ₹83 Cr | ₹29 Cr |
Adjustment | ₹21 Cr | ₹16 Cr | ₹14 Cr | ₹16 Cr | ₹22 Cr |
Changes In working Capital | ₹-31 Cr | ₹-5.55 Cr | ₹-111 Cr | ₹-24 Cr | ₹-12 Cr |
Cash Flow after changes in Working Capital | ₹58 Cr | ₹47 Cr | ₹-15 Cr | ₹76 Cr | ₹39 Cr |
Cash Flow from Operating Activities | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr | ₹31 Cr |
Cash Flow from Investing Activities | ₹-44 Cr | ₹-13 Cr | ₹-84 Cr | ₹-25 Cr | ₹-13 Cr |
Cash Flow from Financing Activities | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr |
Net Cash Inflow / Outflow | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr | ₹0.42 Cr |
Opening Cash & Cash Equivalents | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr | ₹0.41 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr |
Compare Cashflow Statement of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,553.0 Cr | -7.8% | 2% | 41.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹447,596.0 Cr | 0.1% | 6.6% | 60.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,695.0 Cr | -0.5% | 11% | 42.5% | Stock Analytics | |
CIPLA | ₹132,401.0 Cr | -1.2% | 3.4% | 32.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,341.0 Cr | -1.4% | -6% | 11.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,198.0 Cr | -5.4% | -12.8% | 63.3% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -7.8% |
2% |
41.5% |
SENSEX | 2% |
4.5% |
25.2% |
You may also like the below Video Courses